tbuckley/cabot-search huggingface dataset:
Undernutrition, nutritionally acquired immunodeficiency, and tuberculosis control
Authors: Anurag Bhargava
Journal: BMJ (2016)

Link between tuberculosis and undernutrition is clear and fixable

Nutrition is essential to life, health, and protection from disease. Pneumocystis jiroveci pneumonia—the first opportunistic infection associated with AIDS and indicative of advanced immunosuppression—was initially described in undernourished infants in wartime Europe.1 Undernutrition increases the frequency, severity, and fatality of many infections (including tuberculosis (TB)), while infections in turn worsen undernutrition.2 Undernutrition is the commonest cause of secondary immunodeficiency worldwide, which affects both innate and adaptive immunity, and this has been termed nutritionally acquired immune deficiency syndrome.3 Immunodeficiency related to malnutrition contributes to nearly half of deaths from common childhood infections in children under 5 years.4

Undernutrition in adults is an under-recognised driver of TB epidemics, which are declining only slowly in high burden countries despite treatment programmes.5 Large cohort studies have consistently shown a strong, inverse, and exponential relation between body mass index and incidence of TB.6 In the most recent study, new cases of TB were 12 times higher in people with …
Prognostic Impact of Combined Ex Vivo Drug Resistance to Fludarabine, Treosulphan and Mitoxantrone in Childhood Acute Myeloid Leukemia.
Authors: Jan Styczynski, Mariusz Wysocki, Agnieszka Dluzniewska, Krzysztof Czyzewski, Robert Debski, Malgorzata Kubicka, Beata Rafinska, Beata Kolodziej, Edyta Juraszewska, Walentyna Balwierz, Igor Olejnik, Maria Wieczorek, Marta Kuzmicz, Maryna Krawczuk-Rybak, Jolanta Stefaniak, Jerzy Kowalczyk, Wanda Badowska, Tomasz Szczepanski, Danuta Sonta-Jakimczyk, Elzbieta Stanczak, Iwona Malinowska, Michal Matysiak, Benigna Konatkowska, Jacek Wachowiak, Lucyna Kapuscinska, Anna Balcerska
Journal: Blood (2005)
Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms
Authors: Omar Abdel-Wahab, Animesh Pardanani, Jay Patel, Terra Lasho, Adriana Heguy, Ross Levine, Ayalew Tefferi
Journal: Blood (2010)
The role of CHFR expression in ovarian cancer and response to taxane therapy.
Authors: Andrea Elisabeth Wahner Hendrickson, Daniel W. Visscher, Krista M. Goergen, Vivian Negron, Wilma L. Lingle, Ann L. Oberg, Kimberly Kalli, Lynn C. Hartmann, Matthew J. Maurer, Scott H. Kaufmann
Journal: Journal of Clinical Oncology (2013)

5546 Background: CHFR, an E3 ubiquitin ligase that regulates Aurora A and Pololike Kinase 1, plays a critical role in the cellular response to mitotic stress. In particular, cells containing CHFR arrest in G2 when microtubule dynamics are disrupted. Conversely, low CHFR expression is associated with hypersensitivity to mitotic spindle poisons in breast cancer cell lines. Despite the extensive use of taxanes in front line treatment of epithelial ovarian cancer (EOC), little is known about CHFR expression in this disease. We examined CHFR expression and its relationship with clinical characteristics and outcome in women with EOC. Methods: Pretreatment EOC samples from women enrolled in the Mayo Clinic Biospecimen Resource for Ovarian Cancer Research who underwent initial surgical debulking between 1999-2009 were stained in triplicate with anti-CHFR antibodies. Samples were scored in a blinded fashion for CHFR expression. Associations between CHFR staining and histology, grade, and stage were assessed using chi-squared tests; associations between CHFR and overall survival (OS) or time to disease recurrence (TTR) were assessed using Cox proportional hazards models. Results: Samples from 354 women were stained; median age at diagnosis was 60.5 (range 21-93). At a median follow-up of 67 months, 221 women (62%) had died. Across all patients, moderate/strong CHFR staining was associated with poor OS (HR = 1.39, 95% CI: 1.07-1.81, p = 0.015). Moreover, moderate/strong CHFR expression was strongly associated with serous histology (p &lt; 0.0001), high grade (p &lt; 0.0001) and advanced stage (p = 0.0002). To assess whether the association between CHFR expression and OS was related to taxane sensitivity, a subgroup analysis was performed in the subset of patients (N=131) with high-grade serous EOC who received initial platinum/taxane chemotherapy. Moderate/strong CHFR expression failed to correlate with OS (HR=0.91, 95% CI: 0.57-1.45, p = 0.68) or TTR from the start of chemotherapy (HR = 0.85, 95% CI: 0.55-1.31, p = 0.55) in this subset. Conclusions: CHFR expression is associated with poor OS and adverse clinical characteristics in patients with EOC but does not appear to be related to taxane sensitivity in high-grade serous tumors.
TCT-356 Characterizing Non-culprit Coronary Artery Plaques Using Hybrid Near-infrared Spectroscopy and Intravascular Ultrasound: The Rarity of Non-culprit Lesions Having Both a Large Plaque Burden and Large Lipid Burden
Authors: Mohsin Khan, Andrew Borgman, Stacie M. Vanoosterhout, Abbey Mulder, Matthew Elmore, Jessica Campbell, Andrew LaCombe, Andrew O'Brien, Ryan Farley, Samrath Singh, Rishi Puri, Ryan D. Madder
Journal: Journal of the American College of Cardiology (2015)
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
Authors: M Marchetti, G Barosi, F Cervantes, G Birgegård, M Griesshammer, C Harrison, R Hehlmann, J-J Kiladjian, N Kröger, M F McMullin, F Passamonti, A Vannucchi, T Barbui
Journal: Leukemia (2016)
TCT-44 The Impact of Plaque Morphology and Malapposition Area on Late Phase Stent Malapposition: Insight From Optimal Coherence Tomography Sub-study in PRASFIT Elective
Authors: Kenzo Uzu, Toshiro Shinke, Hiromasa Otake, Tomofumi Takaya, Hiroto Kinutani, Masaru Kuroda, Hachidai Takahashi, Daisuke Terashita, Ken-ichi Hirata, Shigeru Saito, Masato Nakamura, Junya Shite, Takashi Akasaka
Journal: Journal of the American College of Cardiology (2015)
Long Term Response After Lenalidomide Treatment for Patients with Multiple Myeloma Relapsed After at Least Two Lines of Therapy.
Authors: Francesco Spina, Vittorio Montefusco, Claudia Crippa, Barbara Oliviero, Massimo Offidani, Francesca Patriarca, Daniela Petro', Monica Galli, Tommasina Guglielmelli, Davide Rossi, Antonietta Pia Falcone, Marianna De Muro, Paolo Corradini
Journal: Blood (2009)
Patients' views on delayed diagnosis in cancer.
Authors: T. H. Gallagher, S. Greene, D. Roblin, J. Calvi, K. Horner, C. Prouty, C. Firneno, C. Lemay, C. Lo, K. Mazor
Journal: Journal of Clinical Oncology (2010)

6098 Background: A patient's perception that his or her cancer diagnosis was delayed is a common reason for malpractice litigation. Better communication with patients who believe their diagnosis was delayed could decrease patient distress and reduce litigation. This study investigated patients' experiences when delayed diagnosis was suspected. Methods: We recruited patients at Kaiser Georgia, Group Health, and Fallon Clinic; eligibility criteria included recent treatment for breast or colorectal cancer, belief that something went wrong during care, that what went wrong was preventable, and that the event caused harm. In 1-hour phone interviews, participants described what occurred, how they were affected, and how the providers involved responded. Recurrent themes were identified using qualitative analysis. Results: Of 78 patients interviewed, 16 believed their diagnosis had been delayed. Some patients felt partial responsibility for the delay (not been sufficiently assertive about symptoms); others held a provider or healthcare system responsible. After diagnosis, treatment became patients' top priority; several referred to “not looking back”. Most patients wanted providers to acknowledge the delay and wanted steps to be taken to prevent similar delay for others. Most wanted an apology, though some stressed the need for action over words. Patients were generally unaware of avenues for providing feedback to the healthcare system, and did not talk with the provider involved about the delay. Some patients felt that their provider avoided discussing the delay, which damaged the provider-patient relationship. Some patients did not return to the provider, so these providers may not ever have learned of the patient's concern. Patients identified ways delays could have been prevented: better training of providers in diagnosing cancer, referral to appropriate specialists, and better communication between healthcare systems, providers, and providers. Conclusions: In our sample, nearly 1 in 5 cancer patients expressed worry about a possible delayed diagnosis, but hesitated to share this concern with their provider. Cancer care providers and health systems should consider structural changes and communication approaches to better address these concerns. No significant financial relationships to disclose.
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy
Authors: M. Moore, S. Gill, T. Asmis, S. Berry, R. Burkes, K. Zbuk, T. Alcindor, A. Jeyakumar, T. Chan, S. Rao, J. Spratlin, P.A. Tang, J. Rothenstein, E. Chan, J. Bendell, F. Kudrik, J. Kauh, S. Tang, L. Gao, S.R.P. Kambhampati, F. Nasroulah, L. Yang, N. Ramdas, P. Binder, E. Strevel
Journal: Annals of Oncology (2016)
TCT-603 Randomized comparison of 9-month stent struts coverage of biolimus and everolimus drug-eluting stents assessed by OCT in patients with STEMI
Authors: Pavel Cervinka, Petr Kala, Martin Jakl, Jan Kanovsky, Andrej Kupec, Radim Špaček, Martin Kvašňák, Hiram Bezerra, Hong Lu
Journal: Journal of the American College of Cardiology (2015)
Histone Deacetylase Inhibitor SAHA Reduces Cytokine Storm and Facilitates Induction of Chimerism When Combined with Anti-CD3 mAb in Conditioning of Recipients.
Authors: Nainong Li, Dongchang Zhao, Chunyan Zhang, Chia-Lei Lin, Mark Kirschbaum, Fouad Kandeel, Stephen Forman, Defu Zeng
Journal: Blood (2007)
TCT-94 Balloon Post-Dilation of the Self-Expanding CoreValve Transcatheter Aortic Valve Bioprosthesis: Procedural Results and In Hospital Outcomes from 3532 patients in the CoreValve US Pivotal and Continued Access Trials
Authors: J. Kevin Harrison, G.C. Hughes, Michael J. Reardon, Robert Stoler, Paul Grayburn, Robert F. Hebeler, Jeffrey Popma
Journal: Journal of the American College of Cardiology (2015)
TCT-309 The impact of Flow and Gradient On The Invasive Assessment of Severe Aortic Stenosis
Authors: Zaher Fanari, Jhapat Thapa, Kamleish Persad, Sumaya Hammami, Michael Kostal, Joseph T. West, Erik S. Marshall, William Weintraub, Andrew Doorey
Journal: Journal of the American College of Cardiology (2015)
TCT-649 Native Valve Calcification Degree Does Not Impact Upon Hemodynamic Performance of an Inflatable and Fully Repositionable Non- Metallic Transcatheter Aortic Valve
Authors: Giuseppe D'Ancona, Stephan Kische, Umut Agma, Jasmin Ortak, Hüseyin Ince
Journal: Journal of the American College of Cardiology (2015)
TCT-748 Outcomes among the Elderly in Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy
Authors: John M. Neathawk, Stewart M. Benton, Jeremy D. Rier, Shawn Shaji, Barbara E. Griffin, Alexandria Panuccio, Sheldon E. Litwin, Valerian Fernandes, Christopher D. Nielsen
Journal: Journal of the American College of Cardiology (2015)
GW27-e0701 Glycemia-specific Prevalence of Microalbuminuria in People with Prehypertension and Ideal Blood Pressure
Authors: Huang Jingjing, Jingjing Huang, Yuemin Sun, Qing Wang, Wenjuan Zhang, Yuxia Gao, Wei Yao, Yongle Li, Xianming Wu, Huanhuan Zhao, Huili Chen
Journal: Journal of the American College of Cardiology (2016)
TCT-577 Early- Versus New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: Results froma Patient-Level Pooled Analysis of Randomized Controlled Trials
Authors: Gennaro Giustino, Olga Salianski, Usman Baber, Samantha Sartori, Melissa Aquino, Giulio G. Stefanini, Martin Leon, Gregg W. Stone, Marie-Claude Morice, Pieter C. Smits, Clemens von Birgelen, Ghada Mikhail, Adnan Kastrati, Alaide Chieffo, Roxana Mehran
Journal: Journal of the American College of Cardiology (2015)
TCT-363 Increased Lipid Content, Macrophage Infiltration And Neovascularization in Culprit Coronary Lesions of Patients With Chronic Kidney Disease
Authors: Jacobo Pena, Yuliya Vengrenyuk, Sawfan Kezbor, Takahiro Yoshimura, Jason Kovacic, Samin K. Sharma, Pedro R. Moreno, Usman Baber, Annapoorna Kini
Journal: Journal of the American College of Cardiology (2015)
TCT-706 Sustained improvement of mitral regurgitation and symptoms after MitraClip® – The results of the Swiss nationwide investigator-initiated prospective registry MitraSwiss
Authors: Daniel Suerder, Catherine Klersy, Giovanni Pedrazzini, Tiziano Moccetti, Stefan Toggweiler, Peiman Jamshidi, Stephan Windecker, Fabien Praz, Stephane Noble, Barbara Naegeli, Osmund Bertel, Peter Buser, Raban Jeger, André Vuilliomenet, Olivier Muller, Oliver Gaemperli, Francesco Maisano, Jürg Grünenfelder, Paul Erne, Roberto Corti
Journal: Journal of the American College of Cardiology (2015)
Correlation of Suppression of FDG PET Uptake with Serum Free Light Chain Levels - Both FDG PET-CT and Serum Clonal Free Light Chain Response Precede and Predict the Likelihood of Subsequent Complete Remission in Newly Diagnosed Multiple Myeloma.
Authors: Ronald Walker, Erik Rasmussen, Federica Cavallo, Laurie Jones-Jackson, Elias Anaissie, Terri Alpe, Joshua Epstein, Frits Van Rhee, Maurizio Zangari, Guido Tricot, John Shaughnessy, Bart Barlogie
Journal: Blood (2005)
A Phase I/II Trial of Vorinostat (SAHA) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0806
Authors: Daniel O. Persky, Hongli Li, Lisa M. Rimsza, Paul M. Barr, Leslie L. Popplewell, Charles L. Bane, Ann Von Gehr, Michael Leblanc, Richard I. Fisher, Sonali M. Smith, Jonathan W. Friedberg
Journal: Blood (2015)
Value of serum estradiol during the perimenopausal and postmenopausal periods at the time of aromatase inhibitor administration.
Authors: T. Nagao, M. Morimoto, K. Okazaki, M. Nakagawa, M. Sasa, A. Tangoku
Journal: Journal of Clinical Oncology (2010)

e11076 Background: Aromatase inhibitor (AI) therapy is being extensively used as postoperative adjuvant therapy in patients with hormone receptor-positive postmenopausal breast cancer. On the other hand, it has been reported that ovarian function was restored when AI was administered to patients who had undergone chemical menopause with chemotherapy or tamoxifen. However, there have been no reports of comprehensive monitoring of estradiol (E2) in breast cancer patients with ordinary menopause who were being administered AI. Methods: Beginning in March 2008, regular monitoring of the serum levels of E2, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) was performed for 66 postmenopausal breast cancer patients who had been started on AI therapy. For this study, we chose anastrozole as the AI. The assays of those hormones were outsourced to a commercial clinical laboratory. Results: In 4 of the 66 patients the serum E2 level was decreased at 3 months but had then increased at 6 months, while in 2 other patients E2 was decreased at both 3 and 6 months but had increased at 9 months. Conclusions: The results indicate that, in some breast cancer patients with ordinary menopause, E2 rebounds following AI therapy. In the future, E2 monitoring should be performed for a larger number of patients being administered AI therapy. No significant financial relationships to disclose.
Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study
Authors: Heinz Ludwig, Elisabeth Rauch, Thomas Kuehr, Adam Zdenek, Adalbert Weissmann, Hedwig Kasparu, Eva-Maria Autzinger, Daniel Heintel, Richard Greil, Wolfram Poenisch, Niklas Zojer, Ercan Müldür
Journal: Blood (2014)
GW27-e0532 All-comers study of safety and efficacy of biodegradable polymer coated Everolimus-eluting coronary stent system [Everoflex] - a median 9-months follow-up study in real world scenario
Authors: Rajasekhar Durgaprasad, Vanajakshamma Velam, Vasudeva Chetty Pakala, Vamsidhar Akkulagari, Latheef Kasala, Sowjenya Gopal, Sreedhar Naik Kanavat
Journal: Journal of the American College of Cardiology (2016)
GW27-e0269 A study on the mechanism of the eNOS/NO system in Ginsenoside Rb1 against the intrinsic aging of mouse brain
Authors: Bin Zhou, Shujie Yu, Lin Wu, Yong Liu, Dinghui Liu, Min Wang, Xianguan Yu, Baoshun Hao, Lin Chen, Xiaoxian Qian
Journal: Journal of the American College of Cardiology (2016)
Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential
Authors: Wen-Lian Chen, Yue-Ying Wang, Aihua Zhao, Li Xia, Guoxiang Xie, Mingming Su, Linjing Zhao, Jiajian Liu, Chun Qu, Runmin Wei, Cynthia Rajani, Yan Ni, Zhen Cheng, Zhu Chen, Sai-Juan Chen, Wei Jia
Journal: Cancer Cell (2016)
TCT-54 A comparison of three-dimensional echocardiography and computed tomography in sizing the D-shaped mitral annulus before transcatheter mitral valve implantation
Authors: George Mak, Philipp Blanke, Kevin Ong, Christopher Naoum, Chris Thompson, Webb John, Robert Moss, Jian Ye, Anson Cheung, Brad Munt, Jonathon A. Leipsic, Jasmine Grewal
Journal: Journal of the American College of Cardiology (2015)
"Prophylactic" Platelet (PLT) Transfusions in the Setting of Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): Similar Clinical Efficacy of Single Donor (SDP) and Random Donor Pooled (RDP) Platelet Products.
Authors: Poliana A. Patah, Emel Gurkan, Rima Saliba, Marcos de Lima, Gabriela Rondon, Carlos A. Ramos, Daniel Couriel, Jonas A. de Souza, Richard Champlin, Benjamin Lichtiger
Journal: Blood (2006)
Plerixafor Is Highly Effective for the Mobilization of Autologous PBSC for Transplant in Children Failing to Mobilize by Conventional Means: International Experience with 40 Children From 19 Centers
Authors: Shalini Shenoy, Kenny W Douglas, Zdenek Korístek, Peter J. Shaw, Jerry Stein, Mohamad Mohty, Julián Sevilla, Karoline Ehlert, Tracey O'Brien, Catherine Roberts, Anselm Lee, Michael Albert, Martin Ebinger, Tina Carter, Jairam Sastry, David Loeb, Mehmet F Ozkaynak, Jignesh Dalal, Caron Strahlendorf, Rakesh K Goyal, Rafael F Duarte
Journal: Blood (2011)
Robust Factor IX Expression Following ZFN-Mediated Genome Editing in An Adult Mouse Model of Hemophilia B
Authors: Xavier M Anguela, Rajiv Sharma, Hojun Li, Virginia Haurigot, Anand Bhagwat, Robert J Davidson, Shangzhen Zhou, Yannick Doyon, Philip D. Gregory, Michael C. Holmes, Katherine A. High
Journal: Blood (2011)
TCT-297 Safety and Efficacy of Intracoronary Nicorandil as Hyperemic Agent for Invasive Physiological Assessment: Patient-Level Pooled Analysis of Current Evidence
Authors: Do-Yoon Kang, Joo Myung Lee, Daiki Kato, Maki Oi, Mamoru Toyofuku, Hiroaki Takashima, Katsuhisa Waseda, Tetsuya Amano, Akiyoshi Kurita, Hiroki Ishihara, Woo-Hyun Lim, Joon-Hyung Doh, Chang-Wook Nam, Nobuhiro Tanaka, Bon-Kwon Koo, Nobukiyo Tanaka
Journal: Journal of the American College of Cardiology (2015)
Phase I/II Study for the Effectivity of Rituximab, Gemcitabin and Oxaliplatin in Relapsed Indolent Lymphoma – An Interim Report.
Authors: Martin Hoffmann, Martin H. Dreyling, H.-P. Böck, Ulrich Dührsen, Joachim Kaesberger, Stephan Kremers, Walter Lindemann, Luisa Mantovani, Michael J. Uppenkamp, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood (2009)
High Frequency of Circulating CD8+ Memory Stem T Cells in Acquired Aplastic Anemia
Authors: Kohei Hosokawa, Pawel Muranski, Xingmin Feng, Danielle M. Townsley, Baoying Liu, Jared Knickelbein, Keyvan Keyvanfar, Bogdan Dumitriu, Sawa Ito, Sachiko Kajigaya, James G. Taylor, Mariana J. Kaplan, Robert B. Nussenblatt, Austin John Barrett, John O'Shea, Neal S. Young
Journal: Blood (2015)
Allogeneic Cytokine-Induced Killer Cells Kill Dendritic Cells Efficiently Resulting in Less Graft-Versus-Host Disease
Authors: Shintaro Mase, Hideaki Maeba, Rie Kuroda, Raita Araki, Toshihiro Fujiki, Hideo Yagita, Akihiro Yachie, Shoichi Koizumi, Ryosei Nishimura
Journal: Blood (2011)
TCT-397 10-year outcome after complete versus incomplete revascularization of patients with multivessel coronary artery disease
Authors: Mineok Chang, Pil Hyung Lee, Jae-Hyung Roh, Se Hun Kang, Hee-Soon Park, Byeong Joo Bae, Cheol Hyun Lee, Min Soo Cho, Jae Seok Bae, Yu Na Kim, Sung-Han Yoon, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park
Journal: Journal of the American College of Cardiology (2015)
TCT-451 Impact of Crossing Strategy On The Incidence Of Periprocedural Myocardial Infarction During Chronic Total Occlusion Percutaneous Coronary Intervention
Authors: Jeffrey R. Stetler, Georgios E. Christakopoulos, Muhammad Nauman J Tarar, Suwetha Amsavelu, Krishna S. Patel, Bavana V. Rangan, Michele Roesle, Shuaib Abdullah, Subhash Banerjee, Emmanouil Brilakis
Journal: Journal of the American College of Cardiology (2015)
Pomolic Acid-Induced Apoptosis in Cells from Chronic Myeloid Leukemic Patients Is Not Affected by the MDR Phenotype and Status of Disease.
Authors: Flavia C. Vasconcelos, Cerli R. Gattas, Janaina Fernandes, Vivian M.D. Rumjanek, Raquel C. Maia
Journal: Blood (2005)
Leukocyte Apoptosis and Inflammation in Iron-Overloaded Patients with Sickle Cell Disease or β-Thalassemia: A Mechanism for Increased Stroke and Disease Severity in Sickle Cell Disease.
Authors: Patrick B. Walter, David W. Killilea, Ellen B. Fung, Annie Lui, Jacqueline Madden, John Porter, Patricia Evans, Bruce N. Ames, Elliott Vichinsky, Paul Harmatz
Journal: Blood (2006)
TCT-354 Tissue Characterization and Phenotype Classification in Patients Presenting With Acute Myocardial Infarction: Insights from iWonder Study
Authors: Cristiano F. Souza, Akiko Maehara, Gary S. Mintz, Mitsuaki Matsumura, Leonardo de Freitas Campos Guimaraes, Eduardo R. Lima, Claudia Alves, Antonio C. Carvalho, Adriano Caixeta
Journal: Journal of the American College of Cardiology (2015)